Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression.
Shinjini KunduBeth G AshinskyMustapha BouhraraErik B DamShadpour DemehriM Shifat-E-RabbiRichard G SpencerKenneth L UrishGustavo K RohdePublished in: Proceedings of the National Academy of Sciences of the United States of America (2021)